High fidelity restriction endonucleases
View Patent ↗Compositions and methods are provided for enzymes with altered properties that involve a systematic approach to mutagenesis and a screening assay that permits selection of the desired proteins. Embodiments of the method are particularly suited for modifying specific properties of restriction endonucleases such as star activity. The compositions includes restriction endonucleases with reduced star activity as defined by an overall fidelity index improvement factor.
1. A composition comprising a variant SalI restriction endonuclease having reduced star activity, wherein the variant SalI restriction endonuclease comprises an amino acid sequence that differs from the amino acid sequence of the parent SalI restriction endonuclease by a mutation at an amino acid position corresponding to position 82 in SEQ ID NO:94.
2. A composition according to claim 1 , wherein the mutation is R82A.
3. A composition comprising a variant SalI restriction endonuclease having reduced star activity, wherein the variant SalI restriction endonuclease comprises an amino acid sequence that differs from the amino acid sequence of the parent SalI restriction endonuclease by a mutation at an amino acid position corresponding to position 93 in SEQ ID NO:94.
4. A composition according to claim 3 , wherein the mutation is K93A.
5. A composition comprising a variant SalI restriction endonuclease having reduced star activity, wherein the variant SalI restriction endonuclease comprises an amino acid sequence that differs from the amino acid sequence of the parent SalI restriction endonuclease by a mutation at an amino acid position corresponding to position 101 in SEQ ID NO:94.
6. A composition according to claim 5 , wherein the mutation is K101A.
7. A composition comprising a variant SalI restriction endonuclease having reduced star activity, wherein the variant SalI restriction endonuclease comprises an amino acid sequence that differs from the amino acid sequence of the parent SalI restriction endonuclease by a mutation at an amino acid position corresponding to position 107 in SEQ ID NO:94.
8. A composition according to claim 7 , wherein the mutation is R107A.